Vascular endothelial growth factor plays a critical role in the formation of the pre-metastatic niche via prostaglandin E2

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2477-2484

  Liu, Shili ^a   Jiang, Man ^a   Zhao, Qiang ^a   Li, Shancheng ^a   Peng, Yanping ^a   Zhang, Pengfei ^a   Han, Mingyong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Cancer metastasis; Molecular mechanism; Pre metastatic niche; Prostaglandin E2; Vascular endothelial growth factor

Indexed keywords

CELECOXIB; PROSTAGLANDIN E2; VASCULOTROPIN; CYCLOOXYGENASE 2 INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; BREAST CANCER CELL LINE; BREAST CARCINOMA; CAPILLARY ENDOTHELIAL CELL; CELL ADHESION; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN FUNCTION; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CANCER TRANSPLANTATION; CELL MOTION; HUMAN; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECONDARY;

ANIMALS; BREAST NEOPLASMS; CELL MOVEMENT; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PYRAZOLES; SULFONAMIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84914666517     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3516     Document Type: Article

References (31)

1. Nguyen DX, Bos PD and Massagué J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284, 2009.
2. Fidler IJ: The organ microenvironment and cancer metastasis. Differentiation 70: 498-505, 2002.
3. Das Roy L, Pathangey LB, Tinder TL, Schettini JL, Gruber HE and Mukherjee P: Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res 11: Jul 30, 2009 (Epub ahead of print). doi: 10.1186/bcr2345
4. Hiratsuka S, Watanabe A, Aburatani H and Maru Y: Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8: 1369-1375, 2006.
5. Kaplan RN, Riba RD, Zacharoulis S, et al: VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827, 2005.
6. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
7. Chen SF, Fei X and Li SH: A new simple method for isolation of microvascular endothelial cells avoiding both chemical and mechanical injuries. Microvasc Res 50: 119-128, 1995.
8. Lu H, Ouyang W and Huang C: Inflammation, a key event in cancer development. Mol Cancer Res 4: 221-233, 2006.
9. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458, 2003.
10. Murdoch C, Muthana M, Coffelt SB and Lewis CE: The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8: 618-631, 2008.
11. Kim S, Takahashi H, Lin WW, et al: Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457: 102-106, 2009.
12. Carmeliet P: VEGF as a key mediator of angiogenesis in cancer. Oncology 69: 4-10, 2005.
13. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
14. Padua D, Zhang XH and Wang Q: TGF beta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77, 2008.
15. Serafini P, Borrello I and Bronte V: Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 16: 53-65, 2006.
16. + myeloid cells that promote metastasis. Cancer Cell 13: 23-35, 2008.
17. Olkhanud PB, Baatar D, Bodogai M, et al: Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res 69: 5996-6004, 2009.
18. Huang Y, Song N, Ding Y, et al: Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis. Cancer Res 69: 7529-7537, 2009.
19. + myeloid cells that promote invasion. Nat Genet 39: 467-475, 2007.
20. Dawson MR, Duda DG, Fukumura D and Jain RK: VEGFR1-activity independent metastasis formation. Nature 461: E4-E5, 2009.
21. Erler JT, Bennewith KL, Cox TR, et al: Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15: 35-44, 2009.
22. Duda DG, Cohen KS, Kozin SV, et al: Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 107: 2774-2776, 2006.
23. Dawson MR, Duda DG, Chae SS, Fukumura D and Jain RK: VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation. PLoS One 4: e6525, 2009.
24. Bos CL, Richel DJ, Ritsema T, et al: Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 36: 1187-1205, 2004.
25. Ma X, Kundu N, Ioffe OB, et al: Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities. Mol Cancer Res 8: 1310-1318, 2010.
26. Narumiya S, Sugimoto Y and Ushikubi F: Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
27. Yang T and Du Y: Distinct roles of central and peripheral prosta-glandin E2 and EP subtypes in blood pressure regulation. Am J Hypertens 25: 1042-1049, 2012.
28. Gupta GP, Nguyen DX, Chiang AC, et al: Mediators of vascular remodeling co-opted for sequential steps in lung metastasis. Nature 446: 765-770, 2007.
29. Nozawa H, Chiu C and Hanahan D: Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103: 12493-12498, 2006.
30. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al: Polarization of tumor-associated neutrophil (TAN) phenotype by TGF-beta: 'N1' versus 'N2' TAN. Cancer Cell 16: 183-194, 2009.
31. Chang SH, Liu CH, Conway R, et al: Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci USA 101: 591-596, 2004.